Follow-The-Filings

FATE Fate Therapeutics

Fate Therapeutics earnings company data as of 7:30 PM ET 8/20

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 13 Aug EPS -0.25
Rev $2.1M

SEC filings

Recent issuer filings from EDGAR · 15 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01
10-Q 10-Q
8-K 5.02,5.07,9.01
8-K 8.01,9.01
8-K 2.02,9.01
10-Q 10-Q
DEFA14A DEFA14A
8-K 2.02,9.01
10-K 10-K
8-K 2.02,9.01
10-Q 10-Q
8-K 7.01,8.01,9.01
8-K 5.02,7.01,9.01
8-K 2.02,2.05,9.01
10-Q 10-Q

Insider forms

Form 3 / 4 / 5 from EDGAR · 5 of 25 shown

Filed Form Detail Links
4 Period Aug 4, 2026 · 2 forms
4 Period Jun 12, 2026 · 3 forms

20 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice